{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:37:59Z","timestamp":1783226279392,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.clinthera.2011.01.014","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T09:06:24Z","timestamp":1298538384000},"page":"2370-2385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"nct00141219","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Dong Eon","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ok","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duck Mi","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ha","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyung Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.01.014_bib1","series-title":"Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms","first-page":"209","article-title":"Part III: Pain terms: A current list with definitions and notes on usage","year":"1994"},{"key":"10.1016\/j.clinthera.2011.01.014_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aen107","article-title":"Neuropathic pain: Emerging treatments","volume":"101","author":"Dray","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clinthera.2011.01.014_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: Systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2011.01.014_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: An overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2011.01.014_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1533-2500.2005.05205.x","article-title":"Pregabalin for pain management","volume":"5","author":"Gajraj","year":"2005","journal-title":"Pain Pract"},{"key":"10.1016\/j.clinthera.2011.01.014_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","article-title":"Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex","volume":"42","author":"Fink","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2011.01.014_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel alpha2delta ligands: Novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.clinthera.2011.01.014_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007938","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2011.01.014_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.jcp.0000084032.22282.ff","article-title":"A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder","volume":"23","author":"Feltner","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.01.014_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.euroneuro.2008.01.004","article-title":"Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies","volume":"18","author":"Stein","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.clinthera.2011.01.014_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600 mg\/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.clinthera.2011.01.014_bib12","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.01.014_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib14","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.01.014_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jpain.2008.05.014","article-title":"Pregabalin for postherpetic neuralgia: Placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief","volume":"9","author":"Stacey","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","article-title":"Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study","volume":"12","author":"T\u00f6lle","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/030079906X80404","article-title":"Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial","volume":"22","author":"van Seventer","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2011.01.014_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpainsymman.2007.09.016","article-title":"Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients","volume":"36","author":"Vernon","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2011.01.014_bib24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2011.01.014_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sleep.2004.07.006","article-title":"Psychometric properties of the Medical Outcomes Study Sleep measure","volume":"6","author":"Hays","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.clinthera.2011.01.014_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejpain.2006.05.002","article-title":"Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain","volume":"11","author":"Rejas","year":"2007","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinthera.2011.01.014_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1041610296002645","article-title":"Clinical global impressions in Alzheimer's clinical trials","volume":"8","author":"Schneider","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.clinthera.2011.01.014_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib31","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2011.01.014_bib32","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1526-4637.2004.04019.x","article-title":"Comorbidities in chronic neuropathic pain","volume":"5","author":"Nicholson","year":"2004","journal-title":"Pain Med"},{"key":"10.1016\/j.clinthera.2011.01.014_bib33","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1468-1331.2010.02979.x","article-title":"Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: A randomized double-blind trial","volume":"17","author":"van Seventer","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2011.01.014_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1526-4637.2010.00824.x","article-title":"Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: Evidence from medical practice in primary care settings","volume":"11","author":"Navarro","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.clinthera.2011.01.014_bib35","first-page":"47","article-title":"Population pharmacokinetics of pregabalin in healthy volunteers, renally impaired patients, and patients with chronic pain","volume":"3","author":"Corrigan","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.clinthera.2011.01.014_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J Clin Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:44Z","timestamp":1758962924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":34,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0149291811000154"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}